On Thursday, San Francisco-based R&D cloud software company Benchling announced that it has acquired Belfast-based Ovewatch Research, a software company for customers working on preclinical biopharma ...

SAN FRANCISCO, Oct. 24, 2016 /PRNewswire/ -- Benchling, the next-generation life science R&D software company, announced that is has raised $7 million in new funding. This latest funding round was led ...

SAN FRANCISCO, Jan. 31, 2017 /PRNewswire/ -- Benchling, the next-generation life science R&D software company, today announced the release of its Molecular Biology 2.0 system, an unprecedented ...

In a field where the laboratory notebook is still considered the state of the art, it’s no wonder a company like Benchling, which provides software for managing life sciences research, was able to nab ...

(Reuters) - Benchling, which develops software tools for scientists and pharmaceutical research organizations, has laid off 74 employees, or 9% of its workforce, its spokesperson confirmed on Friday.

After the last two decades of consumer Internet and mobile innovation, is biotech or bioinformatics the next wave? There are a handful of San Francisco-based startups that cross the bridge between the ...

Sajith Wickramasekara started biotech R&D software company Benchling in his MIT dorm room. Now it's worth $850 million. Sajith Wickramasekara started working on an idea for a cloud-based Crispr design ...

(Reuters) -Benchling, which develops software tools for scientists and pharmaceutical research organizations, has confidentially submitted paperwork with regulators for a stock market listing in New ...

Life sciences-focused cloud startup Benchling has seen its business soar over the last few years due to the pandemic, and a renewed interest in biotech among investors. Now, just as it hits a ...

SAN FRANCISCO, CA — January 27, 2020 /PRNewswire/ — Benchling, the leading life sciences R&D cloud platform, today (Jan. 27) announced the launch of Benchling for Lab Automation, a new solution to ...

Benchling, which develops software tools for scientists and pharmaceutical research organizations, has confidentially submitted paperwork with regulators for a stock market listing in New York, ...